Shares of AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.22 and traded as high as $4.30. AIkido Pharma shares last traded at $3.95, with a volume of 176,146 shares changing hands.
AIkido Pharma Stock Performance
The firm has a 50-day moving average of $6.08 and a 200-day moving average of $3.24. The firm has a market capitalization of $21.89 million, a P/E ratio of -1.03 and a beta of 0.93.
AIkido Pharma Company Profile
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Read More
- Five stocks we like better than AIkido Pharma
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- Best Stocks Under $10.00
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- Manufacturing Stocks Investing
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
